Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
usa auto insurance
Popular Articles

Enrollment In Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary percutaneous hepatic perfusion (PHP(TM)) system for the treatment of cancers of the liver, announced today that it has achieved the seventy-five percent enrollment point of its pivotal Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver. The participating cancer centers in this trial continue to evaluate and enroll patients and the Company remains on target to complete enrollment this year.
generic viagra online
Gathering Of Swine Flu Experts At New York Academy Of Sciences May 28
The very latest information on the 2009 swine influenza (H1N1) outbreak is the subject of a landmark afternoon symposium hosted by the New York Academy of Sciences today, Thursday, May 28. Speakers will discuss the new recombinant virus, epidemiology, treatment, vaccine development and the public health implications of a worldwide pandemic.
News of the day
Changes To HPA Pandemic Flu Media Updates, UK
Government"s announcement that the UK is moving to a new phase in the response to the current pandemic flu virus means there will be a change to the surveillance information that the Health Protection Agency will be able to provide to the media in future.
Diagnostics

Comparative Effectiveness Research Underway At 28 Research Centers

"You hear the pitch in drug ads all the time: "Ask your doctor if this medication is right for you,"" reports MSNBC. However, evidence to show whether a treatment is appropriate for a given patient is often scarce. Matching therapies to patients is further complicated by vast difference in how people respond to medicines. However, a national push for so-called comparative effectiveness research could make that job easier. The economic stimulus package includes $1 billion to support the research. But, it"s not entirely new. Already, 28 research centers funded by the government"s Agency for Health care Research and Quality (AHRQ) have produced a wealth of findings on treatments for many common, chronic conditions. MSNBC outlines some preventive steps and drug treatments for common illnesses that are supported by the evidence. For instance, African-Americans may consider combination therapies that include diuretics and drugs for high blood pressure (Laliberte, 7/22). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009